Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-614P is a **pseudogene** derived from the U6 small nuclear RNA family[1][6][7]. U6 snRNA is a highly conserved component of the spliceosome, the molecular machinery essential for pre-mRNA splicing in eukaryotes[3][5]. However, RNU6-614P represents a non-functional, likely non-transcribed sequence in the human genome, resulting from retrotransposition or gene duplication events[7]. Pseudogenes such as RNU6-614P are numerous in the human genome, and although they are derived from important functional RNAs like U6, they typically lack biological activity, protein coding potential, or participation in canonical snRNP functions[6][7].\n\n**Notes on accuracy and terminology:**\n- *Is_incorrect* is marked as true because RNU6-614P is a pseudogene, not a validated functional drug target or receptor. Pseudogenes generally do not produce functional molecules and are not classified as receptors, enzymes, or other traditional therapeutic targets[1][6][7].\n- The information available supports that RNU6-614P is **not a receptor, does not encode a protein, does not participate in splicing, and is not linked to disease or drug interaction pathways**.\n\n**Related molecular context:**\n- Functional U6 snRNA is involved in **splicing** and the **spliceosomal complex**, which is essential for mRNA maturation[3][5].\n- Numerous copies and pseudogenes of U6 exist throughout the genome, but only a subset are functional; pseudogenes like RNU6-614P are by convention presumed inactive[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 614, pseudogene (RNU6-614P).